Page last updated: 2024-08-22

angiotensin ii and olmesartan medoxomil

angiotensin ii has been researched along with olmesartan medoxomil in 40 studies

Research

Studies (40)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (5.00)	18.2507
2000's	33 (82.50)	29.6817
2010's	5 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukuda, N; Ikeda, M; Koike, H; Miyamoto, M; Mizuno, M; Sada, T; Yanagisawa, H	1
Brunner, HR; Laeis, P; Nussberger, J; Püchler, K; Witte, PU	1
Higaki, J; Matsumoto, K; Moriguchi, A; Morishita, R; Nakagami, H; Nakamura, T; Ogihara, T; Sakonjo, H; Taniyama, Y	1
Egashira, K; Kataoka, C; Kitamoto, S; Koyanagi, M; Takemoto, M; Takeshita, A; Usui, M	1
Fujiyama, S; Higashiyama, S; Iba, O; Iwasaka, T; Jyo, N; Koyama, Y; Maruyama, K; Masaki, H; Matsubara, H; Mori, Y; Nose, A; Nozawa, Y; Ogata, N; Tateishi, E; Tsutsumi, Y; Uchiyama, Y	1
Weber, MA	1
Laeis, P; Püchler, K; Stumpe, KO	1
Ball, KJ; Stumpe, KO; Williams, PA	1
Ichikawa, S; Takayama, Y	1
Higaki, J; Kamide, K; Moriguchi, K; Nagai, M; Ogihara, T; Ohishi, M; Okamura, A; Rakugi, H; Satoh, N; Tuck, ML	1
Miyazaki, M; Takai, S	1
Brunner, HR	1
Ludwig, M; Stumpe, KO	1
Jarvis, B; Warner, GT	1
Hayashi, K; Honda, M; Kubota, E; Matsuda, H; Okubo, K; Ozawa, Y; Saruta, T; Takamatsu, I; Tatematsu, S; Tokuyama, H; Wakino, S	1
Adachi, Y; Fukamizu, A; Garbers, DL; Harada, M; Izumi, T; Kawakami, R; Kishimoto, I; Kuwahara, K; Li, Y; Nakagawa, Y; Nakanishi, M; Nakao, K; Saito, Y; Takahashi, N; Tanimoto, K	1
Franks, AM; Gardner, SF	1
Iwao, H; Izumi, Y; Kim, S; Nakamura, Y; Omura, T; Takeuchi, K; Yoshida, K; Yoshikawa, J; Yoshiyama, M	1
Hobara, N; Inaizumi, K; Kawasaki, H; Kurosaki, Y; Nakamura, A	1
Fujita, T; Inagi, R; Kurokawa, K; Miyata, T; Nangaku, M; Shao, J; Yamada, K	1
Brousil, JA; Burke, JM	1
Dominiak, P; Häuser, W	1
Egashira, K; Hiasa, K; Inoue, S; Ishibashi, M; Kitamoto, S; Ni, W; Nishida, K; Takeshita, A; Usui, M; Zhao, Q	1
Averill, DB; Brosnihan, KB; Ferrario, CM; Gallagher, PE; Ishiyama, Y; Tallant, EA	1
Kobori, H; Navar, LG; Ozawa, Y; Prieto-Carrasquero, MC	1
Charo, IF; Egashira, K; Hiasa, K; Inoue, S; Ishibashi, M; Ishibashi, T; Kitamoto, S; Kura, S; Ohtani, K; Sugaya, T; Takeshita, A; Tsuchihashi, M; Tsuzuki, T; Zhao, Q	1
Egashira, K; Hiasa, K; Ishibashi, M; Takeshita, A; Tan, C; Zhao, Q	1
Dong, J; Fujii, S; Furumoto, T; Goto, D; Imagawa, S; Kitabatake, A; Mishima, T; Nakai, Y; Sobel, BE; Zaman, AK	1
Fujita, M; Hirata, A; Hori, M; Kitakaze, M; Liao, Y; Minamino, T; Nagamachi, Y; Nakatani, T; Ogawa, S; Okada, K; Ozawa, K; Takashima, S; Tomoike, H; Tsukamoto, O; Tsukamoto, Y; Yutani, C	1
Abe, Y; Kimura, S; Kiyomoto, H; Kobori, H; Kohno, M; Miyata, K; Miyatake, A; Nagai, Y; Nishiyama, A; Ozawa, Y; Shokoji, T; Yao, L; Yukimura, T	1
Ferrario, CM; Gallagher, PE; Geary, RL; Igase, M; Strawn, WB	1
Ban, CR; Hosomi, N; Kohno, M; Koziol, JA; Naya, T; Nishiyama, A; Takahashi, T	1
Brunner, HR; Burnier, M; Forclaz, A; Hasler, C; Maillard, M; Nussberger, J	1
Adachi, M; Hirano, T; Ran, J	1
Jones, MR; Laragh, JH; Sealey, JE	1
Igata, H; Imanishi, M; Kawaguchi, N; Kuroita, T; Kusumoto, K; Nagaya, H; Nishigaki, N; Ojima, M; Sakamoto, H; Tsuboi, A; Yamaguchi, F	1
Fujisawa, G; Iwazu, Y; Kimura, M; Kobayashi, E; Kobayashi, T; Kusano, E; Masuda, T; Murakami, T; Muto, S; Nonaka-Sarukawa, M; Sasaki, N; Shimada, K; Shinohara, M; Watanabe, Y	1
Ahmad, S; Batlle, D; Brosnihan, KB; Ferrario, CM; Moniwa, N; Varagic, J; VonCannon, JL; Wysocki, J	1
Baragatti, B; Coceani, F; Pagni, E; Scebba, F	1
Fujigaki, Y; Ishigaki, S; Isobe, S; Kato, A; Miyajima, H; Nishiyama, A; Ohashi, N; Sakao, Y; Tsuji, T; Yasuda, H	1

Reviews

6 review(s) available for angiotensin ii and olmesartan medoxomil

Article	Year
Blood pressure response, but not adverse event incidence, correlates with dose of angiotensin II antagonist. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2001, Volume: 19, Issue:1 Topics: Angiotensin II; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Humans; Imidazoles; Incidence; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Safety; Tetrazoles	2001
The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview. Journal of human hypertension, 2002, Volume: 16 Suppl 2 Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles	2002
Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs. Journal of human hypertension, 2002, Volume: 16 Suppl 2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Clinical Trials, Phase III as Topic; Humans; Imidazoles; Multicenter Studies as Topic; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Tetrazoles	2002
Olmesartan medoxomil. Drugs, 2002, Volume: 62, Issue:9 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Humans; Imidazoles; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Tetrazoles	2002
Olmesartan medoxomil: the seventh angiotensin receptor antagonist. The Annals of pharmacotherapy, 2003, Volume: 37, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Prescription Fees; Receptors, Angiotensin; Tetrazoles	2003
Olmesartan medoxomil: an angiotensin II-receptor blocker. Clinical therapeutics, 2003, Volume: 25, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Clinical Trials as Topic; Drug Interactions; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles	2003

Trials

4 trial(s) available for angiotensin ii and olmesartan medoxomil

Article	Year
Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients. Journal of hypertension, 1997, Volume: 15, Issue:12 Pt 2 Topics: Administration, Oral; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diet, Sodium-Restricted; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Radioimmunoassay; Renin; Safety; Tetrazoles; Treatment Outcome	1997
Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients. Hypertension research : official journal of the Japanese Society of Hypertension, 2001, Volume: 24, Issue:6 Topics: Adult; Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Pulse; Renin; Renin-Angiotensin System; Respiration Disorders; Tetrazoles; Time Factors	2001
Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor. Clinical pharmacology and therapeutics, 2005, Volume: 78, Issue:5 Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypertension; Imidazoles; Lisinopril; Male; Olmesartan Medoxomil; Renin; Renin-Angiotensin System; Tetrazoles	2005
Effects of angiotensin receptor blockers on ambulatory plasma Renin activity in healthy, normal subjects during unrestricted sodium intake. American journal of hypertension, 2007, Volume: 20, Issue:8 Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Biphenyl Compounds; Blood Pressure; Circadian Rhythm; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Imidazoles; Irbesartan; Male; Middle Aged; Olmesartan Medoxomil; Prognosis; Radioimmunoassay; Reference Values; Renin; Renin-Angiotensin System; Single-Blind Method; Sodium Chloride, Dietary; Tetrazoles; Valine; Valsartan	2007

Other Studies

30 other study(ies) available for angiotensin ii and olmesartan medoxomil

Article	Year
Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. European journal of pharmacology, 1995, Oct-16, Volume: 285, Issue:2 Topics: Adrenal Cortex; Anesthesia; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Blood Pressure; Cattle; Guinea Pigs; Imidazoles; In Vitro Techniques; Kinetics; Male; Membranes; Muscle Contraction; Muscle, Smooth, Vascular; Olmesartan Medoxomil; Rats; Rats, Sprague-Dawley; Rats, Wistar; Tetrazoles; Vasoconstrictor Agents	1995
Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation, 2000, Jul-11, Volume: 102, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Cells, Cultured; Collagen; Cricetinae; Extracellular Matrix; Fibroblasts; Fibrosis; Hepatocyte Growth Factor; Humans; Imidazoles; In Vitro Techniques; Male; Matrix Metalloproteinase 1; Muscle Fibers, Skeletal; Myocardium; Olmesartan Medoxomil; Rats; Tetrazoles; Thiazepines; Ventricular Remodeling	2000
Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. Journal of hypertension, 2000, Volume: 18, Issue:12 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Enzyme Inhibitors; Imidazoles; Immunohistochemistry; Male; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Olmesartan Medoxomil; Oxidative Stress; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Superoxides; Systole; Tetrazoles; Transcription Factor AP-1	2000
Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circulation research, 2001, Jan-19, Volume: 88, Issue:1 Topics: Angiopoietin-1; Angiopoietin-2; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cells, Cultured; Cornea; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation; Heparin-binding EGF-like Growth Factor; Imidazoles; In Vitro Techniques; Indoles; Intercellular Signaling Peptides and Proteins; Lymphokines; Maleimides; Membrane Glycoproteins; Naphthalenes; Neovascularization, Physiologic; Olmesartan Medoxomil; Protein Kinase C; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Proteins; Pyridines; Quinazolines; Rabbits; Rats; Receptor Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, TIE-2; Receptors, Angiotensin; Receptors, Cell Surface; Receptors, TIE; RNA Stability; RNA, Messenger; Tetrazoles; Time Factors; Transcriptional Activation; Tyrphostins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2001
Pressure, platelets, and plaque: the central role of angiotensin II in cardiovascular pathology. Concluding comment. The American journal of cardiology, 2001, Apr-19, Volume: 87, Issue:8A Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiovascular Diseases; Fibrinolysis; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Renin-Angiotensin System; Tetrazoles	2001
Relative efficacy of an angiotensin II antagonist compared with other antihypertensive agents. Olmesartan medoxomil versus antihypertensives. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2001, Volume: 19, Issue:1 Topics: Angiotensin II; Antihypertensive Agents; Atenolol; Captopril; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypertension; Imidazoles; Losartan; Multicenter Studies as Topic; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Tetrazoles	2001
The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. American journal of hypertension, 2002, Volume: 15, Issue:1 Pt 1 Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Catecholamines; Diet; Fructose; Glucose Tolerance Test; Heart Rate; Hydralazine; Hyperinsulinism; Hypertrophy, Left Ventricular; Imidazoles; Insulin; Male; Myocardium; Olmesartan Medoxomil; Organ Size; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Renin-Angiotensin System; Sympathetic Nervous System; Tetrazoles	2002
Anti-atherosclerotic efficacy of olmesartan. Journal of human hypertension, 2002, Volume: 16 Suppl 2 Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arteriosclerosis; Biomarkers; Cholesterol; Cholesterol, Dietary; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Imidazoles; In Vitro Techniques; Inflammation; Lipids; Macaca fascicularis; Male; Olmesartan Medoxomil; Tetrazoles; Treatment Outcome	2002
Differential regulation of elevated renal angiotensin II in chronic renal ischemia. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:1 Topics: Angiotensin I; Angiotensin II; Animals; Chronic Disease; Chymases; Cilazapril; Dogs; Hemodynamics; Hypertension, Renal; Imidazoles; Ischemia; Kidney; Male; Oligopeptides; Olmesartan Medoxomil; Peptidyl-Dipeptidase A; Renal Circulation; Renin-Angiotensin System; Serine Endopeptidases; Tetrazoles	2002
Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart. Circulation, 2002, Sep-24, Volume: 106, Issue:13 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Fibrosis; Gene Targeting; Guanylate Cyclase; Heart Rate; Heart Ventricles; Hypertension; Imidazoles; Mice; Mice, Knockout; Myocardium; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Organ Size; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Atrial Natriuretic Factor; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Ventricular Remodeling	2002
Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction. Cardiovascular research, 2003, Volume: 57, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blotting, Northern; Collagen; Diastole; Drug Therapy, Combination; Echocardiography, Doppler; Imidazoles; Male; Models, Animal; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Thiazepines; Ventricular Remodeling	2003
Chronic angiotensin II inhibition increases levels of calcitonin gene-related peptide mRNA of the dorsal root ganglia in spontaneously hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2003, Volume: 26, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Calcitonin Gene-Related Peptide; Ganglia, Spinal; Gene Expression; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Tetrazoles; Thiazepines	2003
Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension (Dallas, Tex. : 1979), 2003, Volume: 42, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cytokines; Hypertension; Imidazoles; Interferon-gamma; Interleukin-4; Kidney; Male; Nephritis, Interstitial; Olmesartan Medoxomil; Polymerase Chain Reaction; Proteinuria; Rats; Rats, Wistar; RNA, Messenger; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; Tetrazoles	2003
[Dosage equivalents of AT1-receptor antagonists available in Germany]. Deutsche medizinische Wochenschrift (1946), 2003, Oct-31, Volume: 128, Issue:44 Topics: Acrylates; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Germany; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Olmesartan Medoxomil; Placebos; Telmisartan; Tetrazoles; Therapeutic Equivalency; Thiophenes; Time Factors; Valine; Valsartan	2003
Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice. Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Chemokine CCL2; Chemokines; Cytokines; Disease Progression; Gene Expression Regulation; Gene Targeting; Humans; Hyperlipoproteinemia Type II; Imidazoles; Inflammation; Inflammation Mediators; Injections, Intramuscular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Olmesartan Medoxomil; Random Allocation; Recombinant Fusion Proteins; Sequence Deletion; Single-Blind Method; Tetrazoles	2004
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Cardiomyopathy, Hypertrophic; Coronary Vessels; Disease Models, Animal; Enzyme Induction; Imidazoles; Ligation; Losartan; Male; Myocardial Infarction; Myocardium; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Ventricular Remodeling	2004
AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Hypertension; Imidazoles; Kidney; Kidney Tubules, Proximal; Male; Olmesartan Medoxomil; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin; Tetrazoles	2004
Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circulation research, 2004, May-14, Volume: 94, Issue:9 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Bone Marrow Transplantation; Chemokine CCL2; Chemotaxis, Leukocyte; Enzyme Inhibitors; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Inflammation; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Monocytes; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Olmesartan Medoxomil; Pilot Projects; Radiation Chimera; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, CCR2; Receptors, Chemokine; Recombinant Fusion Proteins; Superoxide Dismutase; Tetrazoles; Up-Regulation	2004
Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 44, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Cell Division; Chemokine CCL2; Coronary Vessels; DNA-Binding Proteins; Extracellular Matrix Proteins; Gene Expression Profiling; Genetic Therapy; Hypertrophy; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1; Interleukin-6; Macrophages; Male; Mice; Mice, Inbred C57BL; Myosin Heavy Chains; Natriuretic Peptide, Brain; Nonmuscle Myosin Type IIB; Nuclear Proteins; Olmesartan Medoxomil; Receptors, CCR2; Receptors, Chemokine; Recombinant Fusion Proteins; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tunica Media; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vasculitis; Ventricular Remodeling	2004
Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity. Journal of molecular and cellular cardiology, 2004, Volume: 37, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Collagen Type I; Coronary Disease; Coronary Vessels; Fibrosis; Heart Ventricles; Imidazoles; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinase 9; Mice; Mice, Obese; Obesity; Olmesartan Medoxomil; Phosphorylation; Plasminogen Activator Inhibitor 1; Tetrazoles; Thiazepines; Transforming Growth Factor beta	2004
Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation, 2004, Aug-10, Volume: 110, Issue:6 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Valve Stenosis; Apoptosis; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Progression; Endoplasmic Reticulum; Gene Expression Regulation; Heart Failure; Humans; Imidazoles; Ligation; Male; Mice; Mice, Inbred C57BL; Molecular Chaperones; Myocytes, Cardiac; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Inbred WKY; RNA, Messenger; Signal Transduction; Stress, Physiological; Tetrazoles; Thapsigargin; Tunicamycin	2004
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Hydralazine; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; NADPH Oxidases; Olmesartan Medoxomil; Prediabetic State; Rats; Rats, Inbred OLETF; Receptors, Angiotensin; Renin; Tetrazoles; Thiazepines; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta	2005
Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats. American journal of physiology. Heart and circulatory physiology, 2005, Volume: 289, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Aorta, Thoracic; Atenolol; Carboxypeptidases; Carotid Arteries; Gene Expression Regulation, Enzymologic; Hydralazine; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles; Vasodilator Agents	2005
Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia. Neuroscience, 2005, Volume: 134, Issue:1 Topics: Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Brain; Brain Edema; Brain Infarction; Dose-Response Relationship, Drug; Imidazoles; Ischemic Attack, Transient; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Neurologic Examination; Neuroprotective Agents; Olmesartan Medoxomil; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reperfusion; Tetrazoles; Time Factors	2005
Opposing actions of angiotensin II type 1 and 2 receptors on plasma cholesterol levels in rats. Journal of hypertension, 2006, Volume: 24, Issue:1 Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Pressure; Cholesterol; Imidazoles; Lipid Metabolism; Liver; Male; Oligopeptides; Olmesartan Medoxomil; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles	2006
Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models. European journal of pharmacology, 2011, Nov-01, Volume: 669, Issue:1-3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Blood Glucose; Blood Pressure; CHO Cells; Cricetinae; Cricetulus; Dogs; Hypertension; Hypertension, Renal; Imidazoles; Insulin; Male; Olmesartan Medoxomil; Oxadiazoles; Protective Agents; Proteinuria; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Tetrazoles	2011
Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy. American journal of physiology. Heart and circulatory physiology, 2012, May-01, Volume: 302, Issue:9 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Apoptosis; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; Hypertrophy; Hypertrophy, Left Ventricular; Imidazoles; Male; Myocytes, Cardiac; Neovascularization, Physiologic; Olmesartan Medoxomil; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Tetrazoles; Thrombospondin 1; Vascular Endothelial Growth Factor A; Ventricular Dysfunction, Left	2012
Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats. American journal of hypertension, 2013, Volume: 26, Issue:5 Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred Lew; Rats, Transgenic; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Tetrazoles	2013
Functional closure of the ductus arteriosus at birth: evidence against an intermediary role of angiotensin II. Pharmacology, 2014, Volume: 93, Issue:3-4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Animals, Newborn; Ductus Arteriosus; Female; Imidazoles; Male; Mice; Mice, Inbred C57BL; Olmesartan Medoxomil; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vasodilation	2014
Augmented circadian rhythm of the intrarenal renin-angiotensin systems in anti-thymocyte serum nephritis rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2016, Volume: 39, Issue:5 Topics: Angiotensin II; Angiotensinogen; Animals; Antilymphocyte Serum; Circadian Rhythm; Disease Models, Animal; Hydralazine; Kidney; Lymphocytes; Male; Nephritis; Olmesartan Medoxomil; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System	2016